

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 9.23718096 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 8.37120151 |
| 3 | oxygen transport (GO:0015671) | 7.61593233 |
| 4 | gas transport (GO:0015669) | 7.02273823 |
| 5 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.41026698 |
| 6 | heme biosynthetic process (GO:0006783) | 5.85974461 |
| 7 | tetrapyrrole biosynthetic process (GO:0033014) | 5.64099816 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.43870022 |
| 9 | thrombin receptor signaling pathway (GO:0070493) | 5.41240163 |
| 10 | erythrocyte maturation (GO:0043249) | 5.20197348 |
| 11 | regulation of platelet aggregation (GO:0090330) | 5.13310679 |
| 12 | locomotory exploration behavior (GO:0035641) | 4.96113311 |
| 13 | porphyrin-containing compound metabolic process (GO:0006778) | 4.87271914 |
| 14 | platelet formation (GO:0030220) | 4.59807820 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.51285962 |
| 16 | response to insecticide (GO:0017085) | 4.45527053 |
| 17 | definitive hemopoiesis (GO:0060216) | 4.44847569 |
| 18 | heme metabolic process (GO:0042168) | 4.31024106 |
| 19 | positive regulation of granulocyte differentiation (GO:0030854) | 4.20520986 |
| 20 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.16198366 |
| 21 | platelet aggregation (GO:0070527) | 4.08692154 |
| 22 | synaptic vesicle maturation (GO:0016188) | 4.05356492 |
| 23 | response to methylmercury (GO:0051597) | 4.04318217 |
| 24 | protein targeting to Golgi (GO:0000042) | 3.95610816 |
| 25 | vocalization behavior (GO:0071625) | 3.95423389 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 3.88472605 |
| 27 | regulation of platelet activation (GO:0010543) | 3.82167112 |
| 28 | iron ion import (GO:0097286) | 3.80062245 |
| 29 | erythrocyte development (GO:0048821) | 3.78570356 |
| 30 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.73911814 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72520887 |
| 32 | granulocyte differentiation (GO:0030851) | 3.71377835 |
| 33 | protein neddylation (GO:0045116) | 3.66178590 |
| 34 | adenosine receptor signaling pathway (GO:0001973) | 3.60548790 |
| 35 | sodium ion export (GO:0071436) | 3.54345726 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.53086495 |
| 37 | exploration behavior (GO:0035640) | 3.50343368 |
| 38 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.50129423 |
| 39 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.48371156 |
| 40 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.45355257 |
| 41 | positive regulation of receptor recycling (GO:0001921) | 3.44189975 |
| 42 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.43319558 |
| 43 | neuronal action potential propagation (GO:0019227) | 3.40308996 |
| 44 | regulation of histone H3-K9 methylation (GO:0051570) | 3.39499320 |
| 45 | regulation of synaptic vesicle transport (GO:1902803) | 3.38929382 |
| 46 | establishment of protein localization to Golgi (GO:0072600) | 3.38858006 |
| 47 | innate immune response in mucosa (GO:0002227) | 3.38821968 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.34815025 |
| 49 | antibacterial humoral response (GO:0019731) | 3.34711383 |
| 50 | blood coagulation, intrinsic pathway (GO:0007597) | 3.31344000 |
| 51 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.29392851 |
| 52 | hepatocyte apoptotic process (GO:0097284) | 3.29140088 |
| 53 | activation of protein kinase A activity (GO:0034199) | 3.29119629 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 3.28618712 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 3.28618712 |
| 56 | hemoglobin metabolic process (GO:0020027) | 3.28592701 |
| 57 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.27657059 |
| 58 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.26688639 |
| 59 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.25978871 |
| 60 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.22372326 |
| 61 | neuromuscular process controlling posture (GO:0050884) | 3.21967281 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.18807032 |
| 63 | neutrophil activation (GO:0042119) | 3.14851318 |
| 64 | regulation of response to osmotic stress (GO:0047484) | 3.12847185 |
| 65 | negative regulation of norepinephrine secretion (GO:0010700) | 3.11429548 |
| 66 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.09756340 |
| 67 | positive regulation of mast cell activation (GO:0033005) | 3.09318155 |
| 68 | myeloid cell development (GO:0061515) | 3.06441898 |
| 69 | negative regulation of catecholamine secretion (GO:0033604) | 3.03510742 |
| 70 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.02597444 |
| 71 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.02540356 |
| 72 | glutamate secretion (GO:0014047) | 3.02494577 |
| 73 | antimicrobial humoral response (GO:0019730) | 3.00489802 |
| 74 | glutamate receptor signaling pathway (GO:0007215) | 2.99649000 |
| 75 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.97981823 |
| 76 | erythrocyte differentiation (GO:0030218) | 2.97297506 |
| 77 | neuron-neuron synaptic transmission (GO:0007270) | 2.95106781 |
| 78 | bicarbonate transport (GO:0015701) | 2.94116996 |
| 79 | DNA synthesis involved in DNA repair (GO:0000731) | 2.91932109 |
| 80 | protein localization to Golgi apparatus (GO:0034067) | 2.91888882 |
| 81 | neuron cell-cell adhesion (GO:0007158) | 2.91235094 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.90376604 |
| 83 | regulation of receptor recycling (GO:0001919) | 2.89947387 |
| 84 | tetrapyrrole metabolic process (GO:0033013) | 2.89681462 |
| 85 | purine-containing compound salvage (GO:0043101) | 2.87385859 |
| 86 | purine nucleotide salvage (GO:0032261) | 2.86833093 |
| 87 | regulation of integrin activation (GO:0033623) | 2.86633886 |
| 88 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.86627827 |
| 89 | homotypic cell-cell adhesion (GO:0034109) | 2.86095767 |
| 90 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.86066236 |
| 91 | autophagic vacuole fusion (GO:0000046) | 2.85544843 |
| 92 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.85538955 |
| 93 | long-term memory (GO:0007616) | 2.85308830 |
| 94 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.85191311 |
| 95 | neurotransmitter transport (GO:0006836) | 2.84564951 |
| 96 | cellular potassium ion homeostasis (GO:0030007) | 2.84464365 |
| 97 | regulation of early endosome to late endosome transport (GO:2000641) | 2.82383829 |
| 98 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.81780365 |
| 99 | granulocyte activation (GO:0036230) | 2.81433056 |
| 100 | megakaryocyte development (GO:0035855) | 2.81159573 |
| 101 | positive regulation of membrane potential (GO:0045838) | 2.80349254 |
| 102 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.80276625 |
| 103 | gamma-aminobutyric acid transport (GO:0015812) | 2.79596851 |
| 104 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.78922712 |
| 105 | positive regulation of systemic arterial blood pressure (GO:0003084) | 2.77872011 |
| 106 | negative regulation of heart contraction (GO:0045822) | 2.77202711 |
| 107 | negative regulation of adherens junction organization (GO:1903392) | 2.74121511 |
| 108 | negative regulation of focal adhesion assembly (GO:0051895) | 2.74121511 |
| 109 | negative regulation of cell junction assembly (GO:1901889) | 2.74121511 |
| 110 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.72233580 |
| 111 | mucosal immune response (GO:0002385) | 2.71995826 |
| 112 | regulation of lipoprotein metabolic process (GO:0050746) | 2.70328671 |
| 113 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.69411693 |
| 114 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.68943610 |
| 115 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.68828595 |
| 116 | response to pheromone (GO:0019236) | 2.68052939 |
| 117 | response to histamine (GO:0034776) | 2.66076750 |
| 118 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.65434452 |
| 119 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.64972308 |
| 120 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.64844579 |
| 121 | positive regulation of B cell differentiation (GO:0045579) | 2.64684508 |
| 122 | regulation of mast cell degranulation (GO:0043304) | 2.63755236 |
| 123 | succinate metabolic process (GO:0006105) | 2.63513464 |
| 124 | embryonic hemopoiesis (GO:0035162) | 2.63383448 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.63295778 |
| 126 | positive regulation of response to oxidative stress (GO:1902884) | 2.62450029 |
| 127 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.62450029 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.61984334 |
| 129 | regulation of megakaryocyte differentiation (GO:0045652) | 2.60856022 |
| 130 | protein maturation by protein folding (GO:0022417) | 2.60773096 |
| 131 | negative regulation of neurotransmitter transport (GO:0051589) | 2.60721600 |
| 132 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.60324484 |
| 133 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.60187000 |
| 134 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.59670057 |
| 135 | membrane depolarization during action potential (GO:0086010) | 2.58646908 |
| 136 | nuclear pore complex assembly (GO:0051292) | 2.56903876 |
| 137 | leukocyte degranulation (GO:0043299) | 2.56631878 |
| 138 | platelet degranulation (GO:0002576) | 2.56375745 |
| 139 | response to thyroid hormone (GO:0097066) | 2.56195576 |
| 140 | mesodermal cell differentiation (GO:0048333) | 2.55924800 |
| 141 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.55819759 |
| 142 | actin filament capping (GO:0051693) | 2.55723126 |
| 143 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55342044 |
| 144 | organelle membrane fusion (GO:0090174) | 2.55029115 |
| 145 | actin filament polymerization (GO:0030041) | 2.54889321 |
| 146 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.54626497 |
| 147 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.54197281 |
| 148 | organ or tissue specific immune response (GO:0002251) | 2.53686398 |
| 149 | response to lead ion (GO:0010288) | 2.53680544 |
| 150 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53558073 |
| 151 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.53507375 |
| 152 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.53471566 |
| 153 | detection of calcium ion (GO:0005513) | 2.53253718 |
| 154 | pigment biosynthetic process (GO:0046148) | 2.52610645 |
| 155 | negative regulation of histone methylation (GO:0031061) | 2.52578090 |
| 156 | regulation of glucocorticoid secretion (GO:2000849) | 2.51705384 |
| 157 | cellular response to arsenic-containing substance (GO:0071243) | 2.51659596 |
| 158 | cell communication by electrical coupling (GO:0010644) | 2.51463105 |
| 159 | synaptic vesicle endocytosis (GO:0048488) | 2.50948153 |
| 160 | platelet activation (GO:0030168) | 2.49895408 |
| 161 | positive regulation of blood coagulation (GO:0030194) | 2.49632047 |
| 162 | positive regulation of hemostasis (GO:1900048) | 2.49632047 |
| 163 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.48369720 |
| 164 | nerve growth factor signaling pathway (GO:0038180) | 2.46739299 |
| 165 | microtubule depolymerization (GO:0007019) | 2.46272710 |
| 166 | regulation of ARF protein signal transduction (GO:0032012) | 2.45930253 |
| 167 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.42579894 |
| 168 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.41111540 |
| 169 | protein localization to synapse (GO:0035418) | 2.39638745 |
| 170 | proline transport (GO:0015824) | 2.39561538 |
| 171 | positive regulation of insulin secretion (GO:0032024) | 2.38802454 |
| 172 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.38662654 |
| 173 | regulation of erythrocyte differentiation (GO:0045646) | 2.38651990 |
| 174 | transmission of nerve impulse (GO:0019226) | 2.38129024 |
| 175 | oxaloacetate metabolic process (GO:0006107) | 2.37272627 |
| 176 | intraspecies interaction between organisms (GO:0051703) | 2.36493388 |
| 177 | social behavior (GO:0035176) | 2.36493388 |
| 178 | cell differentiation in hindbrain (GO:0021533) | 2.35855081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 6.85590206 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89449437 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89152381 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.78269652 |
| 5 | GATA1_19941826_ChIP-Seq_K562_Human | 3.75687541 |
| 6 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 3.48621302 |
| 7 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 3.32051342 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.20341319 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.86870776 |
| 10 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 2.74310186 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69396881 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.39835585 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.26801092 |
| 14 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19346690 |
| 15 | GATA2_19941826_ChIP-Seq_K562_Human | 2.15875499 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.09851426 |
| 17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02271937 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01929096 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96224500 |
| 20 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94550086 |
| 21 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.86610926 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84981042 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.84776287 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82314897 |
| 25 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82068194 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.79858287 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.71706826 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68174853 |
| 29 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.67183511 |
| 30 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.66713445 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.66164282 |
| 32 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61659815 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.59939554 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56101939 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.54854491 |
| 36 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53320325 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53181710 |
| 38 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.49994815 |
| 39 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44360833 |
| 40 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.44085760 |
| 41 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43499284 |
| 42 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43235426 |
| 43 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42534650 |
| 44 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41821340 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39849143 |
| 46 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39061515 |
| 47 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38818523 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34790287 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.34344835 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33345935 |
| 51 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.28368733 |
| 52 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28004874 |
| 53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27657924 |
| 54 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.27416461 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.26310384 |
| 56 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25556367 |
| 57 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25510569 |
| 58 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24744611 |
| 59 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24516902 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20092627 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18361513 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.16780356 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.16025833 |
| 64 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.15942585 |
| 65 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15626247 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15444698 |
| 67 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14605522 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13409793 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10068038 |
| 70 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.09496164 |
| 71 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.09428968 |
| 72 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.09373290 |
| 73 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08520391 |
| 74 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.04808250 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02503364 |
| 76 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.01900841 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01409152 |
| 78 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.00880109 |
| 79 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00758277 |
| 80 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.00734089 |
| 81 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.00580554 |
| 82 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.00579460 |
| 83 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.99817401 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99598026 |
| 85 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.99465012 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.98682659 |
| 87 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.98196902 |
| 88 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98126687 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97321203 |
| 90 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96467392 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.96195546 |
| 92 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.95444026 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94663904 |
| 94 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94136841 |
| 95 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94130402 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.93539145 |
| 97 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92203067 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92186142 |
| 99 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91976127 |
| 100 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90848232 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.90788008 |
| 102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90690814 |
| 103 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90370987 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88769785 |
| 105 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.88395418 |
| 106 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.87823768 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87148169 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.86870927 |
| 109 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86501474 |
| 110 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85896551 |
| 111 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85838653 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.84340538 |
| 113 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84138357 |
| 114 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.84011187 |
| 115 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83563428 |
| 116 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.83237362 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81886310 |
| 118 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80854169 |
| 119 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.80699792 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.80262258 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.80138046 |
| 122 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.79229499 |
| 123 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.79131975 |
| 124 | AR_19668381_ChIP-Seq_PC3_Human | 0.79123012 |
| 125 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78681446 |
| 126 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78598296 |
| 127 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.77630460 |
| 128 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.77579832 |
| 129 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.77380642 |
| 130 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.77310916 |
| 131 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77184594 |
| 132 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76472000 |
| 133 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.75235582 |
| 134 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.75044953 |
| 135 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74282554 |
| 136 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.74278923 |
| 137 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.73968632 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.73707349 |
| 139 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.73266114 |
| 140 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.72968652 |
| 141 | FUS_26573619_Chip-Seq_HEK293_Human | 0.72848904 |
| 142 | TCF4_23295773_ChIP-Seq_U87_Human | 0.72644140 |
| 143 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.72152452 |
| 144 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.72108815 |
| 145 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.72029767 |
| 146 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.71683015 |
| 147 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71088869 |
| 148 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70903028 |
| 149 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.70129053 |
| 150 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.70024436 |
| 151 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.69713201 |
| 152 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69445609 |
| 153 | STAT3_23295773_ChIP-Seq_U87_Human | 0.69375239 |
| 154 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69286449 |
| 155 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69196327 |
| 156 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.68783353 |
| 157 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.67446817 |
| 158 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67433883 |
| 159 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.67416455 |
| 160 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.67344815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004147_increased_porphyrin_level | 6.18130231 |
| 2 | MP0005464_abnormal_platelet_physiology | 6.06031227 |
| 3 | MP0003656_abnormal_erythrocyte_physiolo | 5.72986123 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.99912516 |
| 5 | MP0008004_abnormal_stomach_pH | 3.29826514 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.79221825 |
| 7 | MP0003303_peritoneal_inflammation | 2.39489628 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.34736781 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.31372642 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.26764390 |
| 11 | MP0000465_gastrointestinal_hemorrhage | 2.24914934 |
| 12 | MP0009745_abnormal_behavioral_response | 2.21565640 |
| 13 | MP0003880_abnormal_central_pattern | 2.19503844 |
| 14 | MP0005083_abnormal_biliary_tract | 2.14042838 |
| 15 | MP0002736_abnormal_nociception_after | 2.12878212 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.01268099 |
| 17 | MP0008260_abnormal_autophagy | 1.99928840 |
| 18 | MP0004270_analgesia | 1.97228412 |
| 19 | MP0002063_abnormal_learning/memory/cond | 1.96190397 |
| 20 | MP0005451_abnormal_body_composition | 1.93776737 |
| 21 | MP0002735_abnormal_chemical_nociception | 1.93602392 |
| 22 | MP0009046_muscle_twitch | 1.89901118 |
| 23 | MP0002064_seizures | 1.89281631 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.87566119 |
| 25 | MP0004043_abnormal_pH_regulation | 1.83010645 |
| 26 | MP0004084_abnormal_cardiac_muscle | 1.79241443 |
| 27 | MP0003724_increased_susceptibility_to | 1.78466937 |
| 28 | MP0002272_abnormal_nervous_system | 1.77866706 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.72550864 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.66859806 |
| 31 | MP0008569_lethality_at_weaning | 1.65755453 |
| 32 | MP0003787_abnormal_imprinting | 1.64279583 |
| 33 | MP0002734_abnormal_mechanical_nocicepti | 1.62816978 |
| 34 | MP0001529_abnormal_vocalization | 1.58823058 |
| 35 | MP0002398_abnormal_bone_marrow | 1.55670403 |
| 36 | MP0004510_myositis | 1.54527060 |
| 37 | MP0009697_abnormal_copulation | 1.53993708 |
| 38 | MP0004130_abnormal_muscle_cell | 1.53372635 |
| 39 | MP0004036_abnormal_muscle_relaxation | 1.53035197 |
| 40 | MP0002822_catalepsy | 1.52805731 |
| 41 | MP0003879_abnormal_hair_cell | 1.46933236 |
| 42 | MP0005646_abnormal_pituitary_gland | 1.46833422 |
| 43 | MP0002733_abnormal_thermal_nociception | 1.46766753 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.46507076 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 1.46129201 |
| 46 | MP0002139_abnormal_hepatobiliary_system | 1.45961473 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.45114541 |
| 48 | MP0002693_abnormal_pancreas_physiology | 1.44259477 |
| 49 | MP0006036_abnormal_mitochondrial_physio | 1.43628410 |
| 50 | MP0008872_abnormal_physiological_respon | 1.42754211 |
| 51 | MP0002132_abnormal_respiratory_system | 1.40840126 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.38866794 |
| 53 | MP0004924_abnormal_behavior | 1.38866794 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.36026644 |
| 55 | MP0000343_altered_response_to | 1.33234223 |
| 56 | MP0004215_abnormal_myocardial_fiber | 1.32449167 |
| 57 | MP0003828_pulmonary_edema | 1.30844763 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.30820691 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.29918645 |
| 60 | MP0001944_abnormal_pancreas_morphology | 1.29790768 |
| 61 | MP0005409_darkened_coat_color | 1.29016463 |
| 62 | MP0001970_abnormal_pain_threshold | 1.27906887 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.27379981 |
| 64 | MP0001486_abnormal_startle_reflex | 1.26318175 |
| 65 | MP0002722_abnormal_immune_system | 1.25880990 |
| 66 | MP0005423_abnormal_somatic_nervous | 1.24421452 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.23501350 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.23501350 |
| 69 | MP0004145_abnormal_muscle_electrophysio | 1.23490131 |
| 70 | MP0008057_abnormal_DNA_replication | 1.23195897 |
| 71 | MP0000689_abnormal_spleen_morphology | 1.21222180 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.20028367 |
| 73 | MP0003111_abnormal_nucleus_morphology | 1.19302892 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.19270870 |
| 75 | MP0003866_abnormal_defecation | 1.14130732 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.13100581 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.11432181 |
| 78 | MP0002078_abnormal_glucose_homeostasis | 1.11220986 |
| 79 | MP0005645_abnormal_hypothalamus_physiol | 1.11164304 |
| 80 | MP0002557_abnormal_social/conspecific_i | 1.10993131 |
| 81 | MP0004484_altered_response_of | 1.09977087 |
| 82 | MP0001188_hyperpigmentation | 1.08963024 |
| 83 | MP0009278_abnormal_bone_marrow | 1.08295883 |
| 84 | MP0004947_skin_inflammation | 1.08211038 |
| 85 | MP0001440_abnormal_grooming_behavior | 1.06991300 |
| 86 | MP0002429_abnormal_blood_cell | 1.05994027 |
| 87 | MP0003868_abnormal_feces_composition | 1.03661494 |
| 88 | MP0005666_abnormal_adipose_tissue | 1.03259506 |
| 89 | MP0003300_gastrointestinal_ulcer | 1.02083122 |
| 90 | MP0005365_abnormal_bile_salt | 1.01961849 |
| 91 | MP0001664_abnormal_digestion | 1.01873307 |
| 92 | MP0001835_abnormal_antigen_presentation | 1.01749389 |
| 93 | MP0001851_eye_inflammation | 1.01104112 |
| 94 | MP0001765_abnormal_ion_homeostasis | 1.00723533 |
| 95 | MP0005310_abnormal_salivary_gland | 1.00428377 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.99872387 |
| 97 | MP0001663_abnormal_digestive_system | 0.99409927 |
| 98 | MP0005360_urolithiasis | 0.99034431 |
| 99 | MP0008877_abnormal_DNA_methylation | 0.98730134 |
| 100 | MP0005535_abnormal_body_temperature | 0.96904272 |
| 101 | MP0003329_amyloid_beta_deposits | 0.96809956 |
| 102 | MP0000490_abnormal_crypts_of | 0.96056852 |
| 103 | MP0000230_abnormal_systemic_arterial | 0.96020063 |
| 104 | MP0000703_abnormal_thymus_morphology | 0.95059549 |
| 105 | MP0004185_abnormal_adipocyte_glucose | 0.93720757 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.93696408 |
| 107 | MP0003123_paternal_imprinting | 0.93494713 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.92877059 |
| 109 | MP0002184_abnormal_innervation | 0.92249034 |
| 110 | MP0002009_preneoplasia | 0.91568110 |
| 111 | MP0000858_altered_metastatic_potential | 0.91203854 |
| 112 | MP0003122_maternal_imprinting | 0.90065129 |
| 113 | MP0009763_increased_sensitivity_to | 0.89659118 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.89362299 |
| 115 | MP0003633_abnormal_nervous_system | 0.88373999 |
| 116 | MP0001661_extended_life_span | 0.88212159 |
| 117 | MP0009333_abnormal_splenocyte_physiolog | 0.87221106 |
| 118 | MP0004142_abnormal_muscle_tone | 0.86231722 |
| 119 | MP0005379_endocrine/exocrine_gland_phen | 0.86177864 |
| 120 | MP0002066_abnormal_motor_capabilities/c | 0.85856323 |
| 121 | MP0006054_spinal_hemorrhage | 0.85683911 |
| 122 | MP0002396_abnormal_hematopoietic_system | 0.85614256 |
| 123 | MP0004957_abnormal_blastocyst_morpholog | 0.84486364 |
| 124 | MP0010386_abnormal_urinary_bladder | 0.83925029 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.83885162 |
| 126 | MP0002229_neurodegeneration | 0.83316978 |
| 127 | MP0005501_abnormal_skin_physiology | 0.83072461 |
| 128 | MP0006072_abnormal_retinal_apoptosis | 0.83064875 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.82190804 |
| 130 | MP0003172_abnormal_lysosome_physiology | 0.81980448 |
| 131 | MP0008995_early_reproductive_senescence | 0.81760449 |
| 132 | MP0001544_abnormal_cardiovascular_syste | 0.80497944 |
| 133 | MP0005385_cardiovascular_system_phenoty | 0.80497944 |
| 134 | MP0004085_abnormal_heartbeat | 0.79542662 |
| 135 | MP0005187_abnormal_penis_morphology | 0.79041841 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.78847645 |
| 137 | MP0002928_abnormal_bile_duct | 0.78572267 |
| 138 | MP0003186_abnormal_redox_activity | 0.77668736 |
| 139 | MP0003763_abnormal_thymus_physiology | 0.77518454 |
| 140 | MP0008874_decreased_physiological_sensi | 0.76418717 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.76194003 |
| 142 | MP0003453_abnormal_keratinocyte_physiol | 0.75857323 |
| 143 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75704058 |
| 144 | MP0003436_decreased_susceptibility_to | 0.75568480 |
| 145 | MP0006138_congestive_heart_failure | 0.75066455 |
| 146 | MP0005220_abnormal_exocrine_pancreas | 0.74986138 |
| 147 | MP0005084_abnormal_gallbladder_morpholo | 0.74429507 |
| 148 | MP0009765_abnormal_xenobiotic_induced | 0.74313873 |
| 149 | MP0003191_abnormal_cellular_cholesterol | 0.74056147 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.73264860 |
| 151 | MP0000313_abnormal_cell_death | 0.73249807 |
| 152 | MP0001730_embryonic_growth_arrest | 0.72633449 |
| 153 | MP0003953_abnormal_hormone_level | 0.72089060 |
| 154 | MP0000716_abnormal_immune_system | 0.71450881 |
| 155 | MP0004885_abnormal_endolymph | 0.71322800 |
| 156 | MP0003283_abnormal_digestive_organ | 0.71269988 |
| 157 | MP0000609_abnormal_liver_physiology | 0.70516856 |
| 158 | MP0005000_abnormal_immune_tolerance | 0.70176866 |
| 159 | MP0002876_abnormal_thyroid_physiology | 0.69974594 |
| 160 | MP0005025_abnormal_response_to | 0.69707644 |
| 161 | MP0008775_abnormal_heart_ventricle | 0.69612009 |
| 162 | MP0002332_abnormal_exercise_endurance | 0.68332894 |
| 163 | MP0002086_abnormal_extraembryonic_tissu | 0.67457415 |
| 164 | MP0000955_abnormal_spinal_cord | 0.67343542 |
| 165 | MP0000249_abnormal_blood_vessel | 0.67121450 |
| 166 | MP0005621_abnormal_cell_physiology | 0.66213838 |
| 167 | MP0009931_abnormal_skin_appearance | 0.66163740 |
| 168 | MP0010329_abnormal_lipoprotein_level | 0.66040324 |
| 169 | MP0005448_abnormal_energy_balance | 0.65628556 |
| 170 | MP0002138_abnormal_hepatobiliary_system | 0.65320745 |
| 171 | MP0000598_abnormal_liver_morphology | 0.65159004 |
| 172 | MP0002420_abnormal_adaptive_immunity | 0.64260154 |
| 173 | MP0005174_abnormal_tail_pigmentation | 0.63924918 |
| 174 | MP0005381_digestive/alimentary_phenotyp | 0.63845870 |
| 175 | MP0001819_abnormal_immune_cell | 0.63172426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.71140526 |
| 2 | Increased mean platelet volume (HP:0011877) | 7.41004262 |
| 3 | * Poikilocytosis (HP:0004447) | 7.37184826 |
| 4 | Abnormal platelet volume (HP:0011876) | 7.02529441 |
| 5 | Menorrhagia (HP:0000132) | 6.41652880 |
| 6 | Epistaxis (HP:0000421) | 5.48122956 |
| 7 | * Acanthocytosis (HP:0001927) | 5.33490163 |
| 8 | Purpura (HP:0000979) | 5.18007932 |
| 9 | Focal motor seizures (HP:0011153) | 4.79029405 |
| 10 | Gingival bleeding (HP:0000225) | 4.74582312 |
| 11 | Reticulocytosis (HP:0001923) | 4.72516031 |
| 12 | Visual hallucinations (HP:0002367) | 4.66989681 |
| 13 | Hypochromic microcytic anemia (HP:0004840) | 4.66989135 |
| 14 | Abnormal platelet function (HP:0011869) | 4.61454655 |
| 15 | Impaired platelet aggregation (HP:0003540) | 4.61454655 |
| 16 | Hyperbilirubinemia (HP:0002904) | 4.12889379 |
| 17 | Abnormal hemoglobin (HP:0011902) | 3.93772141 |
| 18 | Spontaneous hematomas (HP:0007420) | 3.85290435 |
| 19 | Cholelithiasis (HP:0001081) | 3.71150298 |
| 20 | Abnormal gallbladder morphology (HP:0012437) | 3.65898797 |
| 21 | Papilledema (HP:0001085) | 3.60101666 |
| 22 | Focal seizures (HP:0007359) | 3.52770416 |
| 23 | Epileptic encephalopathy (HP:0200134) | 3.36503989 |
| 24 | Depression (HP:0000716) | 3.29561101 |
| 25 | Atonic seizures (HP:0010819) | 3.25624796 |
| 26 | Febrile seizures (HP:0002373) | 3.22908537 |
| 27 | Abnormal social behavior (HP:0012433) | 3.17331182 |
| 28 | Impaired social interactions (HP:0000735) | 3.17331182 |
| 29 | Poor eye contact (HP:0000817) | 3.10836945 |
| 30 | Insomnia (HP:0100785) | 3.07514428 |
| 31 | Abnormality of reticulocytes (HP:0004312) | 3.03696947 |
| 32 | Anxiety (HP:0000739) | 3.02837849 |
| 33 | Hyperlipoproteinemia (HP:0010980) | 3.02234466 |
| 34 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.94904766 |
| 35 | Cholecystitis (HP:0001082) | 2.91479369 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.91479369 |
| 37 | Abnormal number of erythroid precursors (HP:0012131) | 2.89417907 |
| 38 | Absence seizures (HP:0002121) | 2.88889684 |
| 39 | Diaphragmatic weakness (HP:0009113) | 2.78342418 |
| 40 | Truncal ataxia (HP:0002078) | 2.78175000 |
| 41 | Cortical visual impairment (HP:0100704) | 2.73519277 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.73439277 |
| 43 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.67604642 |
| 44 | Dialeptic seizures (HP:0011146) | 2.67325281 |
| 45 | Impaired smooth pursuit (HP:0007772) | 2.65600207 |
| 46 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.64248639 |
| 47 | Conjunctival telangiectasia (HP:0000524) | 2.62068342 |
| 48 | Abnormality of the gallbladder (HP:0005264) | 2.61290907 |
| 49 | Hyperthyroidism (HP:0000836) | 2.61255994 |
| 50 | Protruding tongue (HP:0010808) | 2.60344062 |
| 51 | Abnormality of iron homeostasis (HP:0011031) | 2.58421204 |
| 52 | Myokymia (HP:0002411) | 2.55059034 |
| 53 | Hyperventilation (HP:0002883) | 2.51045910 |
| 54 | Polycythemia (HP:0001901) | 2.50856672 |
| 55 | Macroorchidism (HP:0000053) | 2.49921660 |
| 56 | Hypoglycemic seizures (HP:0002173) | 2.48251725 |
| 57 | Dyschromatopsia (HP:0007641) | 2.46607512 |
| 58 | Papillary thyroid carcinoma (HP:0002895) | 2.45711413 |
| 59 | Osteomalacia (HP:0002749) | 2.42336990 |
| 60 | Postural instability (HP:0002172) | 2.41300118 |
| 61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.37419345 |
| 62 | Status epilepticus (HP:0002133) | 2.36205020 |
| 63 | Gaze-evoked nystagmus (HP:0000640) | 2.34165973 |
| 64 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.30229863 |
| 65 | Bruising susceptibility (HP:0000978) | 2.29921249 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.29848187 |
| 67 | Tinnitus (HP:0000360) | 2.28506584 |
| 68 | Progressive cerebellar ataxia (HP:0002073) | 2.28159828 |
| 69 | Nausea (HP:0002018) | 2.28114244 |
| 70 | Truncus arteriosus (HP:0001660) | 2.27776578 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.26989489 |
| 72 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.26516521 |
| 73 | Abnormality of the fingertips (HP:0001211) | 2.25648211 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23534540 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.21600096 |
| 76 | Action tremor (HP:0002345) | 2.21526121 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.20340153 |
| 78 | Agitation (HP:0000713) | 2.19807349 |
| 79 | Prolonged bleeding time (HP:0003010) | 2.19723238 |
| 80 | Ileus (HP:0002595) | 2.17056696 |
| 81 | Menstrual irregularities (HP:0000858) | 2.16830118 |
| 82 | Global brain atrophy (HP:0002283) | 2.15868592 |
| 83 | Abnormal large intestine physiology (HP:0012700) | 2.13272712 |
| 84 | Hypochromic anemia (HP:0001931) | 2.12478201 |
| 85 | Dysmetric saccades (HP:0000641) | 2.10808572 |
| 86 | Bradykinesia (HP:0002067) | 2.09063725 |
| 87 | Psychosis (HP:0000709) | 2.08703598 |
| 88 | Increased serum ferritin (HP:0003281) | 2.07435121 |
| 89 | Toxemia of pregnancy (HP:0100603) | 2.07094976 |
| 90 | Symptomatic seizures (HP:0011145) | 2.06850683 |
| 91 | Muscular hypotonia of the trunk (HP:0008936) | 2.06020323 |
| 92 | Delusions (HP:0000746) | 2.05975740 |
| 93 | Progressive inability to walk (HP:0002505) | 2.03031083 |
| 94 | Hypoglycemic coma (HP:0001325) | 2.01579422 |
| 95 | Generalized hyperpigmentation (HP:0007440) | 2.00870304 |
| 96 | Progressive microcephaly (HP:0000253) | 1.99539317 |
| 97 | Bowel incontinence (HP:0002607) | 1.98085467 |
| 98 | Abnormality of lateral ventricle (HP:0030047) | 1.97674972 |
| 99 | Broad-based gait (HP:0002136) | 1.97465347 |
| 100 | Ventricular fibrillation (HP:0001663) | 1.96528473 |
| 101 | Eczematoid dermatitis (HP:0000976) | 1.96184403 |
| 102 | Limb hypertonia (HP:0002509) | 1.93005896 |
| 103 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.92772742 |
| 104 | Pheochromocytoma (HP:0002666) | 1.92582505 |
| 105 | Chronic obstructive pulmonary disease (HP:0006510) | 1.92443055 |
| 106 | Obstructive lung disease (HP:0006536) | 1.92443055 |
| 107 | Scanning speech (HP:0002168) | 1.91627917 |
| 108 | Distal lower limb amyotrophy (HP:0008944) | 1.91326515 |
| 109 | Dysdiadochokinesis (HP:0002075) | 1.91076669 |
| 110 | Microcytic anemia (HP:0001935) | 1.91051888 |
| 111 | Decreased circulating renin level (HP:0003351) | 1.90809520 |
| 112 | Abnormal pupillary function (HP:0007686) | 1.90719280 |
| 113 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.90299088 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.89768686 |
| 115 | Volvulus (HP:0002580) | 1.89712944 |
| 116 | Ketoacidosis (HP:0001993) | 1.88208207 |
| 117 | Orthostatic hypotension (HP:0001278) | 1.87486787 |
| 118 | Thyroid carcinoma (HP:0002890) | 1.86052418 |
| 119 | Hyponatremia (HP:0002902) | 1.85966121 |
| 120 | Autoimmune hemolytic anemia (HP:0001890) | 1.85261338 |
| 121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.84902108 |
| 122 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.84902108 |
| 123 | Petechiae (HP:0000967) | 1.84159480 |
| 124 | Aplastic anemia (HP:0001915) | 1.82717040 |
| 125 | Hypertensive crisis (HP:0100735) | 1.81378552 |
| 126 | Insidious onset (HP:0003587) | 1.81337165 |
| 127 | Termporal pattern (HP:0011008) | 1.81337165 |
| 128 | Ankyloglossia (HP:0010296) | 1.81217603 |
| 129 | Poor suck (HP:0002033) | 1.80094217 |
| 130 | Paralysis (HP:0003470) | 1.78307974 |
| 131 | Ragged-red muscle fibers (HP:0003200) | 1.75442663 |
| 132 | Biliary tract neoplasm (HP:0100574) | 1.75319512 |
| 133 | Upper limb muscle weakness (HP:0003484) | 1.75101981 |
| 134 | Acute myeloid leukemia (HP:0004808) | 1.73669291 |
| 135 | Limb ataxia (HP:0002070) | 1.73653331 |
| 136 | Abnormality of macrophages (HP:0004311) | 1.73321642 |
| 137 | Gastrointestinal dysmotility (HP:0002579) | 1.73232388 |
| 138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.70609840 |
| 139 | Increased density of long bones (HP:0006392) | 1.69546543 |
| 140 | Fatigue (HP:0012378) | 1.69112631 |
| 141 | Gastrointestinal infarctions (HP:0005244) | 1.69012904 |
| 142 | Neuroendocrine neoplasm (HP:0100634) | 1.67163576 |
| 143 | Recurrent abscess formation (HP:0002722) | 1.66520472 |
| 144 | Cutaneous photosensitivity (HP:0000992) | 1.65296807 |
| 145 | Slow saccadic eye movements (HP:0000514) | 1.63518914 |
| 146 | Inflammation of the large intestine (HP:0002037) | 1.62962975 |
| 147 | Muscle fiber splitting (HP:0003555) | 1.61795168 |
| 148 | Recurrent bacterial skin infections (HP:0005406) | 1.61661085 |
| 149 | Abnormal auditory evoked potentials (HP:0006958) | 1.60765804 |
| 150 | Hepatosplenomegaly (HP:0001433) | 1.60684896 |
| 151 | Dysautonomia (HP:0002459) | 1.60232055 |
| 152 | Abnormality of sodium homeostasis (HP:0010931) | 1.60112568 |
| 153 | Hemiplegia (HP:0002301) | 1.59756206 |
| 154 | Intention tremor (HP:0002080) | 1.59441826 |
| 155 | Abnormality of binocular vision (HP:0011514) | 1.56964643 |
| 156 | Diplopia (HP:0000651) | 1.56964643 |
| 157 | Arterial thrombosis (HP:0004420) | 1.55979270 |
| 158 | Exercise-induced myalgia (HP:0003738) | 1.55687048 |
| 159 | Increased intramyocellular lipid droplets (HP:0012240) | 1.55588624 |
| 160 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.55487222 |
| 161 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.55487222 |
| 162 | Amyotrophic lateral sclerosis (HP:0007354) | 1.55244040 |
| 163 | Gastrointestinal inflammation (HP:0004386) | 1.55134602 |
| 164 | Neoplasm of the small intestine (HP:0100833) | 1.54948450 |
| 165 | Subaortic stenosis (HP:0001682) | 1.51976324 |
| 166 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.51976324 |
| 167 | Osteomyelitis (HP:0002754) | 1.51802577 |
| 168 | Encephalitis (HP:0002383) | 1.51126448 |
| 169 | Hepatocellular carcinoma (HP:0001402) | 1.50691475 |
| 170 | Decreased motor nerve conduction velocity (HP:0003431) | 1.50299802 |
| 171 | Seborrheic dermatitis (HP:0001051) | 1.50078387 |
| 172 | Spontaneous abortion (HP:0005268) | 1.49921165 |
| 173 | Leiomyosarcoma (HP:0100243) | 1.47986763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.51823829 |
| 2 | BMX | 3.68158108 |
| 3 | SCYL2 | 3.57180331 |
| 4 | TAOK3 | 3.04053817 |
| 5 | MAP3K12 | 2.87307929 |
| 6 | PRPF4B | 2.82226721 |
| 7 | MST4 | 2.79820533 |
| 8 | EIF2AK1 | 2.73038002 |
| 9 | MAP3K4 | 2.58811181 |
| 10 | BMPR2 | 2.46237644 |
| 11 | CDK19 | 2.27420860 |
| 12 | MAP2K7 | 2.26975072 |
| 13 | CAMKK2 | 2.15555839 |
| 14 | MAP3K9 | 2.06975143 |
| 15 | PTK2B | 2.01056468 |
| 16 | STK4 | 1.99836205 |
| 17 | BTK | 1.99520398 |
| 18 | TEC | 1.98775735 |
| 19 | MAP2K4 | 1.96967445 |
| 20 | MINK1 | 1.83507384 |
| 21 | DAPK1 | 1.81332465 |
| 22 | BRSK1 | 1.77956391 |
| 23 | TAOK1 | 1.74081672 |
| 24 | TNIK | 1.70958155 |
| 25 | MAP3K2 | 1.67727193 |
| 26 | DAPK2 | 1.66059377 |
| 27 | PIK3CG | 1.63779342 |
| 28 | CAMKK1 | 1.63233033 |
| 29 | INSRR | 1.63092152 |
| 30 | FGR | 1.55178338 |
| 31 | KSR2 | 1.50981949 |
| 32 | LMTK2 | 1.47387038 |
| 33 | BRSK2 | 1.47121501 |
| 34 | HIPK2 | 1.44257250 |
| 35 | CDC7 | 1.39604228 |
| 36 | STK3 | 1.35091037 |
| 37 | PIM1 | 1.34317536 |
| 38 | ZAP70 | 1.31058679 |
| 39 | MYLK | 1.30767207 |
| 40 | MAP3K11 | 1.29115613 |
| 41 | STK24 | 1.28324624 |
| 42 | CCNB1 | 1.27443843 |
| 43 | SGK2 | 1.26765603 |
| 44 | MAP3K1 | 1.22657805 |
| 45 | PASK | 1.19121477 |
| 46 | GRK5 | 1.18269203 |
| 47 | CASK | 1.17803585 |
| 48 | SGK3 | 1.17409974 |
| 49 | GRK6 | 1.11323674 |
| 50 | NTRK1 | 1.04684044 |
| 51 | PRKD3 | 1.04021473 |
| 52 | BLK | 1.03648356 |
| 53 | TNK2 | 1.02110701 |
| 54 | CLK1 | 1.02072473 |
| 55 | DYRK3 | 1.01390840 |
| 56 | ACVR1B | 1.01385483 |
| 57 | EPHA4 | 1.00368679 |
| 58 | CDK5 | 0.99843620 |
| 59 | PLK2 | 0.99661615 |
| 60 | RIPK4 | 0.98544438 |
| 61 | HCK | 0.95933106 |
| 62 | FRK | 0.93917719 |
| 63 | SYK | 0.92811656 |
| 64 | TRPM7 | 0.90601432 |
| 65 | PRKCG | 0.90019442 |
| 66 | MARK3 | 0.89830159 |
| 67 | PDK1 | 0.86893522 |
| 68 | MARK1 | 0.86842671 |
| 69 | BRD4 | 0.86392072 |
| 70 | AKT3 | 0.84835960 |
| 71 | MAP3K6 | 0.84213857 |
| 72 | YES1 | 0.83939550 |
| 73 | MAP3K3 | 0.83488112 |
| 74 | CAMK1 | 0.82422620 |
| 75 | EEF2K | 0.81815433 |
| 76 | MAPK12 | 0.81286833 |
| 77 | RET | 0.78201761 |
| 78 | NEK1 | 0.75188092 |
| 79 | SGK494 | 0.71806936 |
| 80 | SGK223 | 0.71806936 |
| 81 | PDPK1 | 0.69971535 |
| 82 | RAF1 | 0.69778634 |
| 83 | SIK2 | 0.69761377 |
| 84 | STK16 | 0.69097056 |
| 85 | LYN | 0.68334014 |
| 86 | JAK2 | 0.67457231 |
| 87 | PRKCH | 0.67443746 |
| 88 | MAPKAPK5 | 0.67429043 |
| 89 | RPS6KB1 | 0.67251460 |
| 90 | UHMK1 | 0.66291753 |
| 91 | CDC42BPA | 0.66116992 |
| 92 | BRAF | 0.65742600 |
| 93 | MAPK13 | 0.64997997 |
| 94 | OBSCN | 0.64971364 |
| 95 | PAK1 | 0.64395276 |
| 96 | ILK | 0.63799110 |
| 97 | SGK1 | 0.63205054 |
| 98 | MATK | 0.61832404 |
| 99 | RPS6KA2 | 0.60271119 |
| 100 | CDK12 | 0.60145262 |
| 101 | MAPK11 | 0.59597426 |
| 102 | FES | 0.58111691 |
| 103 | STK11 | 0.56262823 |
| 104 | JAK3 | 0.55798909 |
| 105 | MAP2K1 | 0.54897677 |
| 106 | FLT3 | 0.54868610 |
| 107 | RIPK1 | 0.53320225 |
| 108 | RPS6KA5 | 0.52322964 |
| 109 | NME1 | 0.52239125 |
| 110 | MAP3K10 | 0.52104724 |
| 111 | ERBB2 | 0.50941955 |
| 112 | MAP3K5 | 0.50400165 |
| 113 | MAP2K3 | 0.48183434 |
| 114 | CDK11A | 0.48156808 |
| 115 | CSF1R | 0.47959011 |
| 116 | MAP3K7 | 0.47928308 |
| 117 | DMPK | 0.47344028 |
| 118 | TTN | 0.47252601 |
| 119 | CDK15 | 0.47133477 |
| 120 | PRKACG | 0.47056146 |
| 121 | RPS6KA3 | 0.46826560 |
| 122 | IRAK1 | 0.46614456 |
| 123 | IRAK3 | 0.45730410 |
| 124 | CDK18 | 0.45232404 |
| 125 | MAP2K6 | 0.45038505 |
| 126 | TBK1 | 0.44610161 |
| 127 | PRKAA1 | 0.44267047 |
| 128 | PRKCB | 0.43995638 |
| 129 | VRK1 | 0.43640154 |
| 130 | CDK14 | 0.42949014 |
| 131 | NTRK2 | 0.42658870 |
| 132 | KSR1 | 0.42513776 |
| 133 | CSK | 0.41798682 |
| 134 | MUSK | 0.41471959 |
| 135 | CAMK2A | 0.41263235 |
| 136 | ITK | 0.40410240 |
| 137 | TAOK2 | 0.39993669 |
| 138 | IRAK2 | 0.38841116 |
| 139 | MAPKAPK3 | 0.38132466 |
| 140 | PLK3 | 0.38063762 |
| 141 | CAMK2B | 0.35401536 |
| 142 | PNCK | 0.35375665 |
| 143 | IRAK4 | 0.33822957 |
| 144 | PRKG2 | 0.33752621 |
| 145 | PRKDC | 0.32496339 |
| 146 | WNK1 | 0.32460002 |
| 147 | MAP3K8 | 0.31394742 |
| 148 | PRKAA2 | 0.31281219 |
| 149 | CAMK1G | 0.28361116 |
| 150 | FGFR3 | 0.28342175 |
| 151 | MARK2 | 0.27663337 |
| 152 | DAPK3 | 0.25329862 |
| 153 | TTK | 0.25066454 |
| 154 | FYN | 0.23085556 |
| 155 | SIK3 | 0.22702236 |
| 156 | DYRK1A | 0.22607705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.69809406 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.16525336 |
| 3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.81982854 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.72983886 |
| 5 | Insulin secretion_Homo sapiens_hsa04911 | 2.51475804 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.38665732 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.32851558 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.30465576 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.24438095 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21017446 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14760175 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.03582218 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95576367 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.94602161 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89169130 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.84018318 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.83683138 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80850114 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.80119040 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.74860861 |
| 21 | Long-term depression_Homo sapiens_hsa04730 | 1.74505668 |
| 22 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.73265556 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.71221386 |
| 24 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.70859523 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67073181 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.66948763 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58761513 |
| 28 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.56150699 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.54749193 |
| 30 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.51275076 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50932370 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49746228 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45557877 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.42520620 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42112714 |
| 36 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40823994 |
| 37 | Alcoholism_Homo sapiens_hsa05034 | 1.38960131 |
| 38 | Thyroid cancer_Homo sapiens_hsa05216 | 1.33393319 |
| 39 | Endometrial cancer_Homo sapiens_hsa05213 | 1.31385641 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.31053124 |
| 41 | Cocaine addiction_Homo sapiens_hsa05030 | 1.30648187 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.30202906 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.27492408 |
| 44 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.27091550 |
| 45 | Protein export_Homo sapiens_hsa03060 | 1.25109125 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25099429 |
| 47 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.25055105 |
| 48 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.24683428 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24401728 |
| 50 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.20634584 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.19353101 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.18645192 |
| 53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.16187437 |
| 54 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.14655545 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.14151105 |
| 56 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.13420924 |
| 57 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12225109 |
| 58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.09897082 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09011040 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.05587555 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05219467 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04185572 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.03555175 |
| 64 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.00991264 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00533551 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.99394408 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.99229100 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 0.95381968 |
| 69 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.95054638 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.94953353 |
| 71 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.92713111 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.90104465 |
| 73 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89383504 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89199259 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.89064785 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88959454 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87729715 |
| 78 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85417516 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85375883 |
| 80 | Mismatch repair_Homo sapiens_hsa03430 | 0.85225983 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84418482 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84105897 |
| 83 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84019518 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.83577340 |
| 85 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.83570765 |
| 86 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.82720431 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81528477 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.80275281 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.78904797 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78732100 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76951547 |
| 92 | Apoptosis_Homo sapiens_hsa04210 | 0.75431449 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74237055 |
| 94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73013295 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71473312 |
| 96 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71088649 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70521856 |
| 98 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70425639 |
| 99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67864886 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67505390 |
| 101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66766735 |
| 102 | Shigellosis_Homo sapiens_hsa05131 | 0.66174824 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64745105 |
| 104 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63038320 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62754375 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62744454 |
| 107 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62061385 |
| 108 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.61831962 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.61584603 |
| 110 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61494969 |
| 111 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.59519737 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57975074 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57555701 |
| 114 | Bladder cancer_Homo sapiens_hsa05219 | 0.57483863 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56768517 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53048739 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52928116 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52781154 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51989572 |
| 120 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.51378714 |
| 121 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51238308 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.50146370 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49861387 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49712125 |
| 125 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48537192 |
| 126 | Hepatitis C_Homo sapiens_hsa05160 | 0.44974512 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44662819 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43616409 |
| 129 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43534563 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42621080 |
| 131 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41983567 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41603449 |
| 133 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.41533837 |
| 134 | Prostate cancer_Homo sapiens_hsa05215 | 0.40904084 |
| 135 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39371240 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39343690 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38674200 |
| 138 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.34868348 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.34755696 |
| 140 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34397317 |
| 141 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.34038061 |
| 142 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34035144 |
| 143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33077601 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.32887904 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32395530 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31473730 |
| 147 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31383869 |
| 148 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29962421 |
| 149 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29746171 |
| 150 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27325256 |

